Join the Levoxyl group to help and get support from people like you.
Levoxyl News
FDA Upgrades Recall on 160,000+ Bottles of Thyroid Medication
THURSDAY, July 24, 2025 — The U.S. Food and Drug Administration (FDA) has upgraded a recall of a commonly prescribed thyroid medication due to what it described as "subpotent" active ingredients. The ...
Could the Common Thyroid Medicine Levothyroxine Weaken Bones?
MONDAY, Nov. 25, 2024 – New research suggests that a thyroid medication often prescribed to older Americans may be linked to a common problem in old age – bone loss. Levothyroxine is a synthetic...
RSNA: Levothyroxine Tied to Bone Loss Over Time in Older Adults
MONDAY, Nov. 25, 2024 – Levothyroxine (LT4) use is associated with longitudinal loss of bone mass and density in older adults, according to a study scheduled to be presented at the annual meeting of...
FDA Medwatch Alert: Levoxyl (levothyroxine sodium)
FDA and King Pharmaceuticals notified healthcare professionals of revisions to the PRECAUTIONS, ADVERSE REACTIONS and DOSAGE AND ADMINISTRATION sections of labeling, describing reports of choking,...
Further information
Related condition support groups
Hashimoto's Disease, Underactive Thyroid, Hypothyroidism, Hypothyroidism - After Thyroid Removal, TSH Suppression